Sanofi :  Sanofi provides update on ZynquistaTM (sotagliflozin) type 2 diabetes Phase 3 program and collaboration with Lexicon

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. TSLA
3. WBD
4. AMC
5. FFAI
6. PAA
7. TLT
8. NVDA
9. NUAI
10. MSFT

Go back to Sanofi :  Sanofi provides update on ZynquistaTM (sotagliflozin) type 2 diabetes Phase 3 program and collaboration with Lexicon
BANCO SANTANDER S.A. (NYSE: SAN) Delayed: 14.55 +0.24 (1.68%)
Previous Close $14.31    52 Week High $5.58 
Open $14.59    52 Week Low $3.60 
Day High $14.62    P/E N/A 
Day Low $14.53    EPS $0.00 
Volume 584,674       

SANOFI (NASDAQ: SNY) Delayed: 42.67 +0.19 (0.45%)
Previous Close $42.48    52 Week High $44.76 
Open $42.64    52 Week Low $36.81 
Day High $42.74    P/E N/A 
Day Low $42.48    EPS $0.00 
Volume 206,455